Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


BridgeBio Pharma Reports Dosing Of First Patient In Phase 1/2 Trial Of BBP-681 For Venous, Lymphatic, Venolymphatic Malformations


Benzinga | Feb 2, 2021 07:41AM EST

BridgeBio Pharma Reports Dosing Of First Patient In Phase 1/2 Trial Of BBP-681 For Venous, Lymphatic, Venolymphatic Malformations






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC